CELLEX PHOTOPHERESIS SYSTEM
FDA premarket approval P860003/S095 · decided 2017-09-14
Approval details
- PMA number
- P860003
- Supplement
- S095
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- CELLEX PHOTOPHERESIS SYSTEM
- Generic name
- System, photopheresis, extracorporeal
- Applicant
- Therakos Development Limited
- Date received
- 2017-08-16
- Decision date
- 2017-09-14
- Days to decision
- 29 days
- Decision code
- OK30
- Product code
- LNR
- Advisory committee
- Gastroenterology, Urology
- Expedited review
- No
- Location
- Dublin
- Statement
- Manufacturing site change for the pressure dome assembly component of the Therakos CELLEX Photopheresis Procedural Kit used in the Therakos CELLEX Photopheresis System.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.